Navigation Links
Renal Transplantation in Children Younger Than 6 Years Old

Garcia, et al reported their experience with renal transplantation in 38 children //(40 transplant), ages 1-5 years over a 16 year period. Demographics as well as patient and graft survivals were all reported. The mean age at transplantation was 3.3 ± 1.3 years and the mean weight was 14 kilograms with a range of 5.7-25 kg. The population consisted of 92.5% Caucasian, 7.5% African Brazilian. The main etiology for end-stage renal disease was uropathic/vesicoureteral reflux in 45% of the children followed by glomerulopathy in 25%, congenital/hereditary disease in 10% and hemolytic uremic syndrome at 12.5%. Prior to transplantation, 5% were on hemodialysis, 85% on peritoneal dialysis, and 10% were preemptive transplants.

All the children were followed for at least 6 months posttransplantation, except 2 who died in the first month. In 75% of the cases, kidneys were obtained from living-related donors, an in 25% they were cadaveric. Thirty-nine kidneys were placed extraperitoneal. The primary immunosuppressant therapy consisted of cyclosporine in 61% of the patients, tacrolimus in 39%, mycophenolate in 49% and azathioprine in 51%. A steroid-free protocol was used in 17% of the patients. In the last 21 cases, basiliximab or daclizumab was added.

The group found that there were 13 (32.5%) graft losses. Four of these had artery/vein thromboses, 3 chronic rejections, 3 deaths, and 3 were other causes. The 5-year patient and graft survival rates were 89.6% and 72.2%, respectively. With this information, the group concluded that renal transplantation can be performed with good long term results in children younger than 6 years of age.


Page: 1

Related medicine news :

1. Renal problem alleviated
2. Effect of drug on Renal Cancer
3. Renal problem increased
4. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
5. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
6. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
7. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
8. Clinical Renal Trails Do Not Have Sufficient Women Participants
9. Sunitinib a Promising Agent for Treatment of Renal Cell Cancer
10. New Biotech Drugs to Aid in Renal Cell Carcinoma Treatment
11. MRI Contrast Agent Linked to Complication in Renal Patients
Post Your Comments:

(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... New York, NY (PRWEB) , ... June 24, ... ... lifestyle publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as ... believes that “the most beautiful women in the world, and the most handsome ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... ... Venture Construction Group (VCG) sponsors Luke’s Wings 5th ... Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event raised ... have been wounded in battle and their families. Venture Construction Group is a 2016 ...
(Date:6/24/2016)... Gilbert, Arizona (PRWEB) , ... June 24, 2016 ... ... Gilbert-based practice, is supporting the upcoming 2016 Miss Arizona pageant as its official ... primarily serves Scottsdale, Tempe, Mesa, and Chandler, Arizona. , Dr. Olson says ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
Breaking Medicine Technology: